Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398678
Status:
COMPLETED
Last Update Posted:
2024-05-06
First Post:
2024-05-01
Brief Title:
Anesthesia Management in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Sponsor:
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Organization:
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Study Overview
Official Title:
Retrospective Evaluation of Anesthesia Management and Clinical Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A combined approach of cytoreductive surgery SRC and hyperthermic intraperitoneal chemotherapy HIPEC represents a potential treatment option for patients diagnosed with primary or secondary gastrointestinal or gynaecological malignancies with peritoneal involvement While the surgical phase of the operation macroscopically addresses the cancerous tissue the HIPEC phase targets the microscopic tumour cells that remain after surgery 1 The surgical procedure known as SRC and HIPEC is one of the most complex surgical procedures presenting numerous challenges for both the surgical and anaesthesia teams The haemodynamic haematological and metabolic changes that occur before during and in the early postoperative period are associated with an increased risk of morbidity and mortality It is therefore crucial for anaesthesia management to maintain normovolemia during surgery compensate for hypothermia in the surgical phase and hyperthermia in the HIPEC phase and maintain metabolic and haemodynamic balance throughout the entire procedure
The objective of this study was to retrospectively examine the anaesthesia management and clinical outcomes in patients who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy HIPEC in order to create literature information that can facilitate the early recognition and prevention of haemodynamic haematological and metabolic problems that occur especially in the intraoperative and postoperative period
The objective of this study was to retrospectively examine the anaesthesia management and clinical outcomes in patients who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy HIPEC in order to create literature information that can facilitate the early recognition and prevention of haemodynamic haematological and metabolic problems that occur especially in the intraoperative and postoperative period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None